Cargando…
Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy
The new era of personalized medicine, which integrates the uniqueness of an individual with respect to the pharmacokinetics and pharmacodynamics of a drug, holds promise as a means to provide greater safety and efficacy in drug design and development. Personalized medicine is particularly important...
Autores principales: | Li, Jing, Bluth, Martin H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513217/ https://www.ncbi.nlm.nih.gov/pubmed/23226051 http://dx.doi.org/10.2147/PGPM.S18861 |
Ejemplares similares
-
Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine
por: Ahmed, Shabbir, et al.
Publicado: (2016) -
DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine
por: Arbitrio, Mariamena, et al.
Publicado: (2016) -
Drug metabolizing enzyme activities versus genetic variances for drug of clinical pharmacogenomic relevance
por: Wu, Alan HB
Publicado: (2011) -
Epigenetics of Aging and Alzheimer’s Disease: Implications for Pharmacogenomics and Drug Response
por: Cacabelos, Ramón, et al.
Publicado: (2015) -
Pharmacogenomics and migraine: possible implications
por: Tfelt-Hansen, Peer, et al.
Publicado: (2008)